Counting the Burden: Atopic Dermatitis and Health-related Quality of Life
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis is the most prevalent chronic inflammatory skin condition globally. The burden of atopic dermatitis on children and adults is extensive and there is also significant impact on the lives of patient caregivers and family members. It is important to be able to measure this impact to inform clinical decisions and to plan appropriate patient and carer support. The current impact of atopic dermatitis on children and adults can be measured using several different quality of life questionnaires: the most frequently used are the Dermatology Quality of Life (DLQI), Children's Dermatology Quality of Life and Infants Dermatology Quality of Life. The impact on partners and family can be measured using several atopic dermatitis specific questionnaires or the Family DLQI or the generic Family Reported Outcome Measure, FROM-16.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quality criteria were proposed for measurement properties of health status questionnaires
Terwee, C. B., Bot, S. D. M., de Boer, M. R., van der Windt, D. A. W. M., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. W. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.03.012 · Cited by 10,764 · cited 1×
“The studies assessing the validity of different instruments were required to pass the COSMIN checklist (43).”
BackgroundMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700 · cited 1×
“The minimal clinically important difference (MCID) is the minimal change in score considered clinically significant by clinicians and patients (72).”
BackgroundPalmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978 · cited 1×
“The pathophysiology of AD is postulated to be a combination of epithelial barrier defects, (1) immune system dysfunction (2) and psycho-neurogenic inflammation (3).”
BackgroundHay, R. J., Johns, N. E., Williams, H. C., Bolliger, I. W., Dellavalle, R. P., Margolis, D. J., Marks, R., Naldi, L., Weinstock, M. A., Wulf, S. K., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.446 · Cited by 1,706 · cited 1×
“Using DALYs, the global burden of skin disease survey revealed that eczema causes the highest burden of all skin diseases worldwide (85).”
BackgroundWeidinger, S., Beck, L. A., Bieber, T., Kabashima, K., & Irvine, A. D. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0001-z · Cited by 1,549
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14891 · Cited by 1,181
Williams, H., Robertson, C., Stewart, A., Aït-Khaled, N., Anabwani, G., Anderson, R., Asher, I., Beasley, R., Björkstén, B., Burr, M., et al. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70536-1 · Cited by 998
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14888 · Cited by 684 · cited 1×
“AD has long been considered mainly a childhood problem, but the prevalence in adults ranges between 3–5% (33).”
BackgroundBeattie, P. E., & Lewis-Jones, M. S. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07185.x · Cited by 526 · cited 1×
“The impact of AD on children is comparable to other childhood chronic diseases such as cerebral palsy, epilepsy and cystic fibrosis (23).”
BackgroundLEWIS-JONES, S. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01047.x · Cited by 478 · cited 1×
“Children with AD are often affected on a daily basis including problems when feeding, changing clothes and playing, thus depriving them of a ‘normal childhood’(25).”
BackgroundThe family impact of childhood atopic dermatitis: The Dermatitis Family Impact Questionnaire
Lawson, Lewis-Jones, Finlay, Reid, & Owens (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02034.x · Cited by 434
Yew, Y. W., Thyssen, J. P., & Silverberg, J. I. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.09.035 · Cited by 309
Vermaes, I. P. R., van Susante, A. M. J., & van Bakel, H. J. A. (2012) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsr081 · Cited by 264 · cited 1×
“Siblings of children with chronic conditions may have the same QoL as their peers (107), but it has also been suggested that siblings may have increased levels of distress (102).”
BackgroundLong, K. A., Lehmann, V., Gerhardt, C. A., Carpenter, A. L., Marsland, A. L., & Alderfer, M. A. (2018) · Psycho-Oncology · doi:10.1002/pon.4669 · Cited by 218
Moore, K., David, T. J., Murray, C. S., Child, F., & Arkwright, P. D. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07082.x · Cited by 149
Chalmers, J. R., Simpson, E., Apfelbacher, C. J., Thomas, K. S., Kobyletzki, L., Schmitt, J., Singh, J. A., Svensson, Å., Williams, H. C., Abuabara, K., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14773 · Cited by 125 · cited 1×
“At the HOME III meeting Eczema Area and Severity Index (EASI ) was recommended as the instrument for the outcome disease severity (45), HOME IV recommended Patient Oriented Eczema Measure (POEM) as the PRO for measuring symptoms (46).”
MethodInternational development of the Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)
McKenna, S. P., Whalley, D., Dewar, A. L., Erdman, R. A. M., Kohlmann, T., Niero, M., Baró, E., Cook, S. A., Crickx, B., Frech, F., et al. (2005) · Quality of Life Research · doi:10.1007/s11136-004-4231-z · Cited by 91
Jobanputra, R., & Bachmann, M. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00073.x · Cited by 71 · cited 1×
“It is responsive to change (57, 58) with high test–retest reliability (59, 60).”
Background
Metadata
- Authors
- Ali, F., Vyas, J., & Finlay, A.
- Venue
- Acta Dermato Venereologica
- Published
- 2020
- Volume
- 100
- Issue
- 12
- Pages
- adv00161
- ISSN
- 0001-5555 (ISSN-L)
- 1651-2057
- OpenAlex
- W3027152065
- Cited by
- 211
- References
- 19
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.